Approved Immunotherapy Shrinks, Eliminates Rare, Aggressive Melanoma, Clinical Trial Finds

FRIDAY, Jan. 30, 2026— An already-approved immunotherapy drug can dramatically shrink — or even eliminate — tumors associated with a rare and aggressive form of melanoma, a new clinical trial has found.About 71% of desmoplastic melanoma patients tr...